Journal of Clinical Biochemistry and Nutrition最新文献

筛选
英文 中文
Helicobacter pylori infection and oxidative stress. 幽门螺杆菌感染和氧化应激。
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-08-02 DOI: 10.3164/jcbn.24-109
Hidekazu Suzuki, Miwa Hirai
{"title":"<i>Helicobacter pylori</i> infection and oxidative stress.","authors":"Hidekazu Suzuki, Miwa Hirai","doi":"10.3164/jcbn.24-109","DOIUrl":"10.3164/jcbn.24-109","url":null,"abstract":"<p><p><i>Helicobacter pylori</i> (<i>H. pylori</i>) infection promotes the migration of polymorphonuclear leukocytes from the gastric mucosal microcirculation through chemokine induction, leading to the excessive production of ROS. Like eukaryotes, <i>H. pylori</i> possesses superoxide dismutase and catalase, and is resistant to ROS from host polymorphonuclear leukocytes. Oxidants such as monochloramine produced by ROS cause chronic inflammation in the gastric mucosa. <i>H. pylori</i>-derived virulence factor m1-type VacA induces intracellular ROS accumulation and autophagy, which degrades the <i>H. pylori</i>-derived oncoprotein, CagA. In CD44v9-positive gastric cancer stem-like cells, reduced-type glutathione levels increase within the cell because of the cystine transporter on the cell surface, wherein oxidative stress-induced autophagy no longer occurs. As a result, the oncoprotein CagA accumulates in the cells, thus becoming tumorigenic.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"178-182"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579850/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of celiac disease in patients with type 1 diabetes mellitus: a single-center cross-sectional cohort study. 1 型糖尿病患者中乳糜泻的患病率:一项单中心横断面队列研究。
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-06-14 DOI: 10.3164/jcbn.24-39
Yuki Nishimoto, Naoko Hashimoto, Nozomi Kido, Aya Irahara, Takehito Takeuchi, Michinori Takabe, Shunji Ishihara, Yoshikazu Kinoshita, Takeshi Ohara
{"title":"Prevalence of celiac disease in patients with type 1 diabetes mellitus: a single-center cross-sectional cohort study.","authors":"Yuki Nishimoto, Naoko Hashimoto, Nozomi Kido, Aya Irahara, Takehito Takeuchi, Michinori Takabe, Shunji Ishihara, Yoshikazu Kinoshita, Takeshi Ohara","doi":"10.3164/jcbn.24-39","DOIUrl":"10.3164/jcbn.24-39","url":null,"abstract":"<p><p>Type 1 diabetes mellitus (T1DM) may be associated with other autoimmune diseases. Celiac disease (CD), another autoimmune disorder that mainly affects the small intestine, is caused by intolerance to gluten ingestion. CD has a higher prevalence in patients with T1DM than in the general population. However, the prevalence of CD in patients with T1DM in Japan is unknown. This study investigated the prevalence of CD in Japanese patients with T1DM. We included 115 patients with T1DM treated at Hyogo Brain and Heart Center from December 2020 to April 2021. A questionnaire survey about dietary habits and abdominal symptoms was administered, and serum anti-tissue transglutaminase (TTG) antibody titers were determined for all participants. A CD (CD-seropositive) diagnosis was based on TTG levels >10 U/ml. Fifty-eight patients (50.4%) had some abdominal symptoms (such as constipation, diarrhea, and abdominal pain). The average TTG-IgA antibody titer was 0.75 ± 0.49 U/ml and negative (<10 U/ml) in all patients. In conclusion, the prevalence of CD among patients with T1DM at our hospital was 0%. Thus, the prevalence of CD in Japan is low compared to that in other countries, even among patients with T1DM, who are considered to have high comorbidity rates.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"213-216"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579853/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanism of lipid peroxidation of liposomes by cold atmospheric pressure plasma jet irradiation. 冷大气压等离子体射流辐照脂质体的脂质过氧化机理。
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-08-09 DOI: 10.3164/jcbn.24-72
Tokuko Takajo, Koichi Saito, Kazunori Tsuchida, Shunji Kato, Kiyotaka Nakagawa, Akitoshi Okino, Kazunori Anzai
{"title":"Mechanism of lipid peroxidation of liposomes by cold atmospheric pressure plasma jet irradiation.","authors":"Tokuko Takajo, Koichi Saito, Kazunori Tsuchida, Shunji Kato, Kiyotaka Nakagawa, Akitoshi Okino, Kazunori Anzai","doi":"10.3164/jcbn.24-72","DOIUrl":"10.3164/jcbn.24-72","url":null,"abstract":"<p><p>Liposome lipid peroxidation induced by cold atmospheric pressure plasma jet (CAPPJ) irradiation was investigated. The formation of thiobarbituric acid reactive substances (TBARS), an indicator of lipid peroxidation final products, as a function of irradiation was observed. Lipid radicals, peroxidation reaction intermediates generated by CAPPJ irradiation, were confirmed by increased NBD-pen fluorescence intensity. Additionally, lipid peroxidation products, liposomal phosphatidylcholine (PC) isomers, were analyzed by LC-MS/MS. Products specific to singlet oxygen (<sup>1</sup>O<sub>2</sub>) oxidation, 16:0/10-hydroperoxy-8<i>E</i>,12<i>Z</i>-octadecanoic acid (10-8<i>E</i>,12<i>Z</i>-HpODE) PC and 16:0/12-9<i>E</i>,13<i>E</i>-HpODE PC, were not detected, but radical oxidation specific products 16:0/13-9<i>E</i>,11<i>E</i>-HpODE PC and 16:0/9-10<i>E</i>,12<i>E</i>-HpODE PC were. This suggests that during CAPPJ irradiation, radicals, rather than <sup>1</sup>O<sub>2</sub>, are the primary reactive species of lipid peroxidation. This is also supported by the β-carotene quenching of <sup>1</sup>O<sub>2</sub> not suppressing TBARS and lipid radical generation. Also, neither TBARS formation nor lipid radical generation were suppressed by SOD, indicating that the superoxide radical (O<sub>2</sub> <sup>•-</sup>) is not responsible for the lipid peroxidation reaction. As the CAPPJ irradiation of water produces large quantities of hydroxyl radical (<sup>•</sup>OH) and <sup>•</sup>OH scavengers decreased the amount of TBARS produced by CAPPJ irradiation, it is highly plausible that <sup>•</sup>OH is the primary species involved in CAPPJ-induced liposome lipid peroxidation.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"183-189"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579849/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterized factors of subjects who were first time diagnosed as hyperglycemia more than 126 mg/dl during annual or biannual medical checkups: a case-control study in Japan. 日本一项病例对照研究:年度或半年度体检中首次被诊断为高血糖超过 126 毫克/分升的受试者的特征因素。
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-08-20 DOI: 10.3164/jcbn.24-98
Miwako Minami, Tomohiro Imamura, Ayako Takamori, Hiromu Minagawa, Rina Matsuo, Junko Miyakawa, Kenichi Izumi, Shoichiro Ohta, Kohei Yamanouchi, Nobuya Souta, Kyosuke Yamamoto, Sadatosi Tsuji, Tsukuru Umemura, Keizo Anzai, Yuji Hirai, Kazuma Fujimoto, Takuya Kishi
{"title":"Characterized factors of subjects who were first time diagnosed as hyperglycemia more than 126 mg/dl during annual or biannual medical checkups: a case-control study in Japan.","authors":"Miwako Minami, Tomohiro Imamura, Ayako Takamori, Hiromu Minagawa, Rina Matsuo, Junko Miyakawa, Kenichi Izumi, Shoichiro Ohta, Kohei Yamanouchi, Nobuya Souta, Kyosuke Yamamoto, Sadatosi Tsuji, Tsukuru Umemura, Keizo Anzai, Yuji Hirai, Kazuma Fujimoto, Takuya Kishi","doi":"10.3164/jcbn.24-98","DOIUrl":"10.3164/jcbn.24-98","url":null,"abstract":"<p><p>The present study examined factors in subjects diagnosed with hyperglycemia during periodic medical checkups. In total, 9,324 subjects (males: 4,532, females: 4,792) visited the Takagi Hospital for medical checkups in 2019. Eighty-two subjects (59 males) whose fasting blood glucose exceeded 126 mg/dl for the first time during the annual or biannual follow-up were included. Sex- and age-matched controls were used. Data from cases with hyperglycemia were compared to data from themselves one or two years before hyperglycemia. Body mass index (BMI), waist circumference, fatty liver, and blood pressure were higher in cases than in controls. Fasting blood glucose and hemoglobin A1c were higher in cases. Blood test results indicated that triglyceride, low-density lipoprotein (LDL) cholesterol, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and γ-glutamyl transpeptidase (γ-GTP), were significantly enhanced in cases. Multiple logistic regression analysis revealed that BMI, waist circumference, blood pressure, triglyceride, ALT, and γ-GTP were significant independent risk factors for cases with hyperglycemia. These risk factors were already enhanced in the cases of themselves in one or two years before hyperglycemia. In conclusion, BMI, waist circumference, blood pressure, and fatty liver indicated by ALT and γ-GTP were exacerbated concomitant with hyperglycemia, and increases in these factors preceded hyperglycemia.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"217-221"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579854/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of cerium oxide on iron metabolism in mice. 氧化铈对小鼠铁代谢的影响
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-08-27 DOI: 10.3164/jcbn.24-38
Yuki Kanome, Shunki Ohtomo, Masaharu Nakatsu, Masahiro Kohno, Koji Fukui
{"title":"Effect of cerium oxide on iron metabolism in mice.","authors":"Yuki Kanome, Shunki Ohtomo, Masaharu Nakatsu, Masahiro Kohno, Koji Fukui","doi":"10.3164/jcbn.24-38","DOIUrl":"10.3164/jcbn.24-38","url":null,"abstract":"<p><p>The use of metal nanoparticles such as cerium oxide nanoparticles (nanoceria) in living organisms is attracting increasing attention. We administered nanoceria to chronic kidney disease model rats, including a 5/6 nephrectomy model and adenine administration model rats, and reported high phosphorus adsorption capacity and renal function improvement effects of nanoceria. However, the iron ion concentration in the serum fluctuated significantly after administration. Therefore, we investigated changes in proteins related to iron metabolism following administration of nanoceria to normal mice without chronic kidney disease over different periods of time. Nanoceria were administered to 10-week-old C57BL/6 mice for 4 or 12 weeks. Another group was administrated lanthanum carbonate, which is currently used as a phosphorus adsorbent. The amount of iron in the serum and the concentration of transferrin in the liver were significantly increased following nanoceria administration, and the amount of iron in the liver was significantly decreased. There were no changes in serum hepcidin, ferroportin, cholesterol, or low-density lipoprotein levels. These results indicate that nanoceria administration can affect iron metabolism in mice. Although the detailed mechanism remains unknown, caution is warranted when considering biological utilization in the future.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"190-196"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovative novel candy made from a low-solubility amorphous material promotes saliva secretion: a randomized, double-blind, placebo-controlled crossover comparative trial. 由低溶解度无定形材料制成的创新糖果可促进唾液分泌:随机、双盲、安慰剂对照交叉比较试验。
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-08-09 DOI: 10.3164/jcbn.24-103
Shinpei Kawakami, Sadao Mori, Shota Kawasaki, Eisaku Nishimura, Mariko Yoshikawa, Akane Yamaguchi, Yuko Matsui, Toshihiro Kawama, Ichiro Saito
{"title":"Innovative novel candy made from a low-solubility amorphous material promotes saliva secretion: a randomized, double-blind, placebo-controlled crossover comparative trial.","authors":"Shinpei Kawakami, Sadao Mori, Shota Kawasaki, Eisaku Nishimura, Mariko Yoshikawa, Akane Yamaguchi, Yuko Matsui, Toshihiro Kawama, Ichiro Saito","doi":"10.3164/jcbn.24-103","DOIUrl":"10.3164/jcbn.24-103","url":null,"abstract":"<p><p>Saliva has antioxidant properties, washes away food residues, and helps maintain the oral environment; thus, decreased saliva secretion can have negative consequences. This study examined how slow-soluble innovative candy, named low-solubility amorphous material, affects oral indices such as saliva secretion and halitosis in a randomized, double-blind, placebo-controlled, crossover comparative study. Twenty-four healthy individuals with low saliva production were given one piece of low-solubility amorphous material or placebo candy and their saliva secretion was measured over 20 min. Before and after participants used the test food, we measured the concentrations of three volatile sulfur compounds involved in halitosis and the secretion rate of secretory immunoglobulin A, and participants completed the Profile of Mood States Second Edition (POMS2) and a visual analog scale (VAS). As a result, saliva secretion increased significantly in low-solubility amorphous material candy condition, compared to placebo candy. Furthermore, changes in the hydrogen sulfide concentration, POMS2 Total Mood Disturbance and Vigor-Activity scores, and oral \"moisture\" and \"refreshed feeling\" scores on the VAS were improved more by low-solubility amorphous material candy use than by placebo. Low-solubility amorphous material candy may help improve the oral environment by increasing saliva secretion and reducing halitosis-related substances and may improve mood.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"222-227"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579848/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710220","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
General and sex-specific effects of vitamin D against atrial fibrillation and young-onset ischemic stroke: a Mendelian randomization series. 维生素 D 对心房颤动和年轻缺血性中风的一般影响和性别特异性影响:孟德尔随机系列研究。
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-07-12 DOI: 10.3164/jcbn.24-79
Yap-Hang Chan, Jie V Zhao, C Mary Schooling, Shiu-Lun Au Yeung, Yuen-Kwun Wong, Ka-Wing Au, Clara S Tang, Chloe Yu Yan Cheung, Aimin Xu, Pak-Chung Sham, Tai-Hing Lam, Karen Siu-Ling Lam, Hung-Fat Tse
{"title":"General and sex-specific effects of vitamin D against atrial fibrillation and young-onset ischemic stroke: a Mendelian randomization series.","authors":"Yap-Hang Chan, Jie V Zhao, C Mary Schooling, Shiu-Lun Au Yeung, Yuen-Kwun Wong, Ka-Wing Au, Clara S Tang, Chloe Yu Yan Cheung, Aimin Xu, Pak-Chung Sham, Tai-Hing Lam, Karen Siu-Ling Lam, Hung-Fat Tse","doi":"10.3164/jcbn.24-79","DOIUrl":"10.3164/jcbn.24-79","url":null,"abstract":"<p><p>Whether vitamin D deficiency causes atrial fibrillation and ischemic stroke of young onset was unknown. We derived a Genetic Risk Score for vitamin D from 3,922 subjects in Hong Kong and applied it in an independent sample (<i>n</i> = 1,297) for clinical outcomes. Primary endpoint was a composite of atrial fibrillation and/or ischemic stroke. A second study was performed in the UK Biobank (<i>n</i> = 392,010; 46% men; 14,878 atrial fibrillation and 4,050 ischemic stroke cases, vs 374,102 controls). After 76 ± 46 months, 240 primary endpoints (18.5%) were adjudicated. Higher genetically-predicted vitamin D independently predicted reduced primary endpoint [odds ratio = 0.83 (0.72 to 0.95), <i>p</i> = 0.008]. Mendelian randomization analyses indicated vitamin D was causally protective against the primary endpoint [odds ratio = 0.81 (95% CI: 0.65 to 0.98)]. Independent analyses in the UK Biobank revealed that vitamin D was protective against young-onset ischemic stroke <50 years and atrial fibrillation combined [odds ratio = 0.36 (95% CI 0.14 to 0.94)], with predominant effect amongst men [odds ratio = 0.28 (95% CI 0.09 to 0.91)] compared to women [odds ratio = 0.60 (95% CI: 0.11 to 3.22)]. In conclusion, vitamin D may protect against young-onset ischemic stroke through preventing atrial fibrillation. Investigating the sex-specifc effects of vitamin D deficiency may elucidate sex disparities of atrial fibrillation in the young.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"228-236"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579857/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Female patients with end-stage renal failure treated by hemodialysis had a low mortality rate and small patient number compared to male patients: 5-year follow-up study in Japan. 与男性患者相比,接受血液透析治疗的终末期肾衰竭女性患者死亡率低、人数少:日本 5 年随访研究。
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-09-06 DOI: 10.3164/jcbn.24-141
Kuniyasu Takagi, Takuya Kishi, Taku Goto, Kohei Yamanouchi, Kazuhiko Yoshikawa, Tomohiro Imamura, Shiki Nakayama, Keizo Anzai, Yuichiro Akiyoshi, Akira Kitajima, Koji Onozawa, Ayako Takamori, Kazuma Fujimoto
{"title":"Female patients with end-stage renal failure treated by hemodialysis had a low mortality rate and small patient number compared to male patients: 5-year follow-up study in Japan.","authors":"Kuniyasu Takagi, Takuya Kishi, Taku Goto, Kohei Yamanouchi, Kazuhiko Yoshikawa, Tomohiro Imamura, Shiki Nakayama, Keizo Anzai, Yuichiro Akiyoshi, Akira Kitajima, Koji Onozawa, Ayako Takamori, Kazuma Fujimoto","doi":"10.3164/jcbn.24-141","DOIUrl":"10.3164/jcbn.24-141","url":null,"abstract":"<p><p>This study aimed to evaluate gender differences of hemodialysis patients in adverse events, gastrointestinal bleeding, and bone fractures during 5 year longitudinal follow-up period in the regional core hospital in Japan. This study included 151 patients with maintenance hemodialysis for end-stage renal failure at Takagi Hospital in December 2017. All the patients, divided into females-group of 61 and males-group of 90. Data were evaluated in the electronic medical record. Multivariate analysis indicated a decrease in diabetes mellitus (odd ratio: 2.3, 95% confidence interval: 1.1-4.8, <i>p</i> = 0.03) and less mortality in those younger than 75 years old (odd ratio: 0.2, 95% confidence interval: 0.1-0.8, <i>p</i> = 0.02) were characterized factors in females. Gastrointestinal bleeding were not different between genders. Bone fractures were high in females (females: 34.4% vs males: 18.9%; <i>p</i><0.03), whereas the mortality rate of bone fractured patients was markedly high in males (females: 28.6% vs males: 76.5%; <i>p</i> = 0.003) with lower body bone fractures. In conclusion, diabetes mellitus-induced end-stage renal failure was less common in females. The mortality rate during hemodialysis was higher in males less than 75 years old with increased mortality with lower bone fractures.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"237-240"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579847/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of gut microbiota in inflammatory bowel disease pathogenesis. 肠道微生物群在炎症性肠病发病机制中的作用。
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-09-06 DOI: 10.3164/jcbn.24-112
Yuji Naito, Tomohisa Takagi
{"title":"Role of gut microbiota in inflammatory bowel disease pathogenesis.","authors":"Yuji Naito, Tomohisa Takagi","doi":"10.3164/jcbn.24-112","DOIUrl":"10.3164/jcbn.24-112","url":null,"abstract":"<p><p>The role of the gut microbiota, especially bacterial flora, in the pathogenesis of inflammatory bowel disease (IBD) is becoming clearer. Advances in gut microbiota analysis and the use of gnotobiotics models have underscored the importance of gut bacteria and their metabolites in the progression of IBD. Fecal microbiota transplantation has shown promise in clinical trials for ulcerative colitis started as Advanced Medical Care B in Japan, raising expectations for its outcomes. This review explores the gut microbiota's role in IBD, encompassing both current knowledge and future prospects.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"175-177"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579855/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of omega-3 fatty acids on sleep: a systematic review and meta-analysis of randomized controlled trials. 欧米伽-3 脂肪酸对睡眠的影响:随机对照试验的系统回顾和荟萃分析。
IF 2 4区 医学
Journal of Clinical Biochemistry and Nutrition Pub Date : 2024-11-01 Epub Date: 2024-08-09 DOI: 10.3164/jcbn.24-36
Kaori Shimizu, Yui Kuramochi, Kohsuke Hayamizu
{"title":"Effect of omega-3 fatty acids on sleep: a systematic review and meta-analysis of randomized controlled trials.","authors":"Kaori Shimizu, Yui Kuramochi, Kohsuke Hayamizu","doi":"10.3164/jcbn.24-36","DOIUrl":"10.3164/jcbn.24-36","url":null,"abstract":"<p><p>Omega-3 long-chain polyunsaturated fatty acids (LC-PUFAs) have been reported to improve sleep quality in several studies, but meta-analyses have been inconclusive. We conducted this study to investigate the effects of omega-3 LC-PUFAs on sleep in clinical trials. The study was planned in accordance with the criteria of the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-2020), and was performed by searching PubMed, The Cochrane Library, and Ichushi-web databases. Randomized controlled trials and clinical trials with control groups were included. Finally, eight studies were selected for inclusion in this study. Sleep efficiency was significantly higher in the omega-3 LC-PUFA group than in the control group, while sleep latency and total sleep duration did not differ significantly. Subjectively assessed sleep was significantly improved by omega-3 LC-PUFA, but heterogeneity was so high that a subgroup analysis based on dose of omega-3 supplementation was performed. It showed low heterogeneity and significant improvement in the omega-3 LC-PUFA group compared with the control group. Omega-3 LC-PUFAs have been shown to may improve sleep quality. Further studies are needed to confirm the relationship between omega-3 LC-PUFAs and sleep. The protocol for this review was registered in UMIN000052527.</p>","PeriodicalId":15429,"journal":{"name":"Journal of Clinical Biochemistry and Nutrition","volume":"75 3","pages":"204-212"},"PeriodicalIF":2.0,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11579846/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142710190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信